InvestorsHub Logo
Followers 129
Posts 2150
Boards Moderated 1
Alias Born 12/27/2007

Re: None

Monday, 06/12/2017 11:25:32 AM

Monday, June 12, 2017 11:25:32 AM

Post# of 12450
Nice move today , News like Patent ruling regarding Par Pharma drug and NDA submission of Tadalafil expected within next 2-3 Weeks .


NDA submission for Tadalafil (erectile dysfunction) in June or July >> FDA approval in 1H 2018 (Peak Sales $120-150 Million)

NDA REsubmission for Rizaport(Migraine) in July or early August >>
FDA approval 1Q 2018 (Peak Sales $50-60 Million)

Patent ruling regarding the Par Pharma Drug (opioid dependence) in June 2017 >> Market Launch expected in 1H 2018 (Peak Sales $70-80 Million)

Start Phase 2a for Montulukast (Alzheimer disease) in June >> Phase 2a Results in 4Q 2017 (BLOCKBUSTER Candidate)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IGXT News